Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 81

1.

Topical delivery of niacinamide: influence of neat solvents.

Iliopoulos F, Sil BC, Monjur Al Hossain ASM, Moore DJ, Lucas RA, Lane ME.

Int J Pharm. 2020 Feb 11:119137. doi: 10.1016/j.ijpharm.2020.119137. [Epub ahead of print]

PMID:
32057889
2.

Topical Delivery of Niacinamide: Influence of Binary and Ternary Solvent Systems.

Zhang Y, Kung CP, Sil BC, Lane ME, Hadgraft J, Heinrich M, Sinko B.

Pharmaceutics. 2019 Dec 10;11(12). pii: E668. doi: 10.3390/pharmaceutics11120668.

3.

Preparation, Characterisation, and Topical Delivery of Terbinafine.

Hossain ASMMA, Sil BC, Iliopoulos F, Lever R, Hadgraft J, Lane ME.

Pharmaceutics. 2019 Oct 22;11(10). pii: E548. doi: 10.3390/pharmaceutics11100548.

4.

Preparation, Characterization and Dermal Delivery of Methadone.

Kung CP, Sil BC, Hadgraft J, Lane ME, Patel B, McCulloch R.

Pharmaceutics. 2019 Oct 2;11(10). pii: E509. doi: 10.3390/pharmaceutics11100509.

5.

3-O-ethyl-l-ascorbic acid: Characterisation and investigation of single solvent systems for delivery to the skin.

Iliopoulos F, Sil BC, Moore DJ, Lucas RA, Lane ME.

Int J Pharm X. 2019 Jul 19;1:100025. doi: 10.1016/j.ijpx.2019.100025. eCollection 2019 Dec.

6.

A Preliminary Investigation of Additive Manufacture to Fabricate Human Nail Plate Surrogates for Pharmaceutical Testing.

Sil BC, Patel A, Crowther JM, Moore DJ, Hadgraft J, Hilton ST, Lane ME.

Pharmaceutics. 2019 May 28;11(6). pii: E250. doi: 10.3390/pharmaceutics11060250.

7.

A comparison of the in vitro permeation of niacinamide in mammalian skin and in the Parallel Artificial Membrane Permeation Assay (PAMPA) model.

Zhang Y, Lane ME, Hadgraft J, Heinrich M, Chen T, Lian G, Sinko B.

Int J Pharm. 2019 Feb 10;556:142-149. doi: 10.1016/j.ijpharm.2018.11.065. Epub 2018 Dec 6.

PMID:
30529662
8.

Monitoring Drug Crystallization in Percutaneous Penetration Using Localized Nanothermal Analysis and Photothermal Microspectroscopy.

Goh CF, Moffat JG, Craig DQM, Hadgraft J, Lane ME.

Mol Pharm. 2019 Jan 7;16(1):359-370. doi: 10.1021/acs.molpharmaceut.8b01027. Epub 2018 Dec 20.

PMID:
30525649
9.
10.

Topical delivery of climbazole to mammalian skin.

Paz-Alvarez M, Pudney PDA, Hadgraft J, Lane ME.

Int J Pharm. 2018 Oct 5;549(1-2):317-324. doi: 10.1016/j.ijpharm.2018.07.058. Epub 2018 Jul 25.

11.

Topical delivery of anthramycin II. Influence of binary and ternary solvent systems.

Haque T, Rahman KM, Thurston DE, Hadgraft J, Lane ME.

Eur J Pharm Sci. 2018 Aug 30;121:59-64. doi: 10.1016/j.ejps.2018.05.002. Epub 2018 May 7.

PMID:
29746912
12.

Polymeric Nano-Encapsulation of Curcumin Enhances its Anti-Cancer Activity in Breast (MDA-MB231) and Lung (A549) Cancer Cells Through Reduction in Expression of HIF-1α and Nuclear p65 (Rel A).

Khan MN, Haggag YA, Lane ME, McCarron PA, Tambuwala MM.

Curr Drug Deliv. 2018 Feb 14;15(2):286-295. doi: 10.2174/1567201814666171019104002.

PMID:
29065834
13.

Application of three-dimensional printing for colon targeted drug delivery systems.

Charbe NB, McCarron PA, Lane ME, Tambuwala MM.

Int J Pharm Investig. 2017 Apr-Jun;7(2):47-59. doi: 10.4103/jphi.JPHI_32_17. Review.

14.

A novel non-invasive diagnostic sampling technique for cutaneous leishmaniasis.

Taslimi Y, Sadeghipour P, Habibzadeh S, Mashayekhi V, Mortazavi H, Müller I, Lane ME, Kropf P, Rafati S.

PLoS Negl Trop Dis. 2017 Jul 13;11(7):e0005750. doi: 10.1371/journal.pntd.0005750. eCollection 2017 Jul.

15.

Use of buccal morphine in the management of pain in children with life-limiting conditions: Results of a laboratory study.

McCulloch R, Sattar M, Henderson EM, Lane ME, Bluebond-Langner M.

Palliat Med. 2018 Feb;32(2):554-558. doi: 10.1177/0269216317717192. Epub 2017 Jun 20.

16.

Developing Transdermal Applications of Ketorolac Tromethamine Entrapped in Stimuli Sensitive Block Copolymer Hydrogels.

Mallandrich M, Fernández-Campos F, Clares B, Halbaut L, Alonso C, Coderch L, Garduño-Ramírez ML, Andrade B, Del Pozo A, Lane ME, Calpena AC.

Pharm Res. 2017 Aug;34(8):1728-1740. doi: 10.1007/s11095-017-2181-8. Epub 2017 May 24.

17.

Caffeic acid phenethyl ester is protective in experimental ulcerative colitis via reduction in levels of pro-inflammatory mediators and enhancement of epithelial barrier function.

Khan MN, Lane ME, McCarron PA, Tambuwala MM.

Inflammopharmacology. 2018 Apr;26(2):561-569. doi: 10.1007/s10787-017-0364-x. Epub 2017 May 20.

18.

Topical delivery of anthramycin I. Influence of neat solvents.

Haque T, Rahman KM, Thurston DE, Hadgraft J, Lane ME.

Eur J Pharm Sci. 2017 Jun 15;104:188-195. doi: 10.1016/j.ejps.2017.03.043. Epub 2017 Mar 31.

PMID:
28373034
19.

Effect of allergens and irritants on levels of natural moisturizing factor and corneocyte morphology.

Koppes SA, Ljubojević Hadžavdić S, Jakasa I, Franceschi N, Riethmüller C, Jurakić Tončic R, Marinovic B, Raj N, Rawlings AV, Voegeli R, Lane ME, Haftek M, Frings-Dresen MH, Rustemeyer T, Kezic S.

Contact Dermatitis. 2017 May;76(5):287-295. doi: 10.1111/cod.12770. Epub 2017 Mar 14.

20.

In vitro permeation and disposition of niacinamide in silicone and porcine skin of skin barrier-mimetic formulations.

Haque T, Lane ME, Sil BC, Crowther JM, Moore DJ.

Int J Pharm. 2017 Mar 30;520(1-2):158-162. doi: 10.1016/j.ijpharm.2017.01.054. Epub 2017 Jan 31.

PMID:
28153652

Supplemental Content

Loading ...
Support Center